Back to Show
Horizons from PBS News
The promise of obesity drugs and their potential risks
Season 2026
Episode 9
Once a relatively obscure class of drugs used for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects over 100 million Americans. Horizons moderator William Brangham explores the great promise of the drugs and the potential concerns surrounding them with Dr. Jody Dushay, Dr. Rekha B. Kumar, Dr. Anna Lembke and Dr. Ziyad Al-Aly.
Support Provided By
26:46
Why we need to talk more about menopause and its health consequences
26:46
Why Khan Academy’s founder thinks AI tools can transform education for the better
26:46
As misinformation spreads and mistrust deepens, can the U.S. handle another pandemic?
26:46
A look at ‘super agers’ and the science behind longer, sharper lives
26:46
Will more Americans embrace renewable energy after the latest oil price surge?
26:46
The alarming rise of cancer in young adults and steps that could lower the risk
26:46
How the Artemis moon missions are shaping the next era of exploration
26:46
Can AI companionship cure loneliness – or deepen it?
26:46
The science behind exercise and why it's good for our bodies
26:46
How Olympians prepare for the pressure of the world stage
26:46
How sports betting is changing our brains and behavior